KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Recaticimab in adult heterozygous familial hypercholesterolaemia (REMAIN-3): a multicentre, randomized, double-blind, placebo-controlled Phase 3 study.Cardiovasc ResPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40911402无 PMCID2025-Oct-240.98未发现恶性肿瘤人群证据。无 KM 图
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.N Engl J MedPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40888725无 PMCID2025-Oct-230.98未发现恶性肿瘤人群证据。无 KM 图
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.N Engl J MedPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 41025556无 PMCID2025-Oct-230.98未发现恶性肿瘤人群证据。无 KM 图
Sex-Specific Mediation of Pre-Quit Smoking Reduction: Secondary Analysis of a Randomized Controlled Trial Extending Varenicline Preloading.Nicotine Tob Res入排复审未纳入:未发现恶性肿瘤人群证据。PMID 40380787PMC125399212025-Oct-220.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial.Eur Heart J已检查 3 张 PubMed Figure,均未识别为 KM 图:Structured Graphical Abstract:AI 判定为 other;Figure 1:AI 判定为 other;Figure 2:AI 判定为 flow diagram。PMID 41120118PMC125399282025-Oct-220.98未发现恶性肿瘤人群证据。无 KM 图
Changes in frailty based on minimally important difference and the impact of spironolactone on frailty in heart failure with preserved ejection fraction: insights from the TOPCAT trial.Open HeartPMID 41125402PMC125485962025-Oct-220.98未发现恶性肿瘤人群证据。已完成
Sustained resolution of enthesitis and peripheral arthritis over 104 weeks with bimekizumab in axial spondyloarthritis.RMD OpenPMID 41125403PMC125502792025-Oct-220.98未发现恶性肿瘤人群证据。已完成
Everolimus and Low-Dose Tacrolimus After Heart Transplant in Children: A Randomized Clinical Trial.JAMA疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 40960806PMC124446522025-Oct-210.98未发现恶性肿瘤人群证据。无 KM 图
Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary Syndrome.J Am Heart Assoc入排复审未纳入:未发现恶性肿瘤人群证据。PMID 41065238PMC126845872025-Oct-210.98未发现恶性肿瘤人群证据。无 KM 图
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial.J Clin Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 40802908无 PMCID2025-Oct-200.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Pre-existing infiltration with T cells and CD14+ myeloid cells is associated with treatment response to imiquimod in primary and recurrent vulvar high-grade squamous intraepithelial lesions.J Immunother Cancer已检查 5 张 PubMed Figure,均未识别为 KM 图:Figure 1:AI 判定为 flow diagram;Figure 2:AI 判定为 other;Figure 3:AI 判定为 other;Figure 4:AI 判定为 other;Figure 5:AI 判定为 other。PMID 41120128PMC125427092025-Oct-200.90The study is a Phase III randomized controlled trial with a drug intervention (imiquimod) in an oncology context. However, the reported results do not include a primary or key secondary time-to-event efficacy endpoint (such as OS, PFS, DFS, EFS, RFS, TTP, Kaplan-Meier curve, or Hazard Ratio). The primary outcome described is the rate of clinical response at a fixed time point (16 weeks) and immune microenvironment analysis. Therefore, it does not meet the eligibility criteria for a Kaplan-Meier digitization cohort.无 KM 图
Effect of vitamin D supplementation during pregnancy and lactation on the development of infants born to Tanzanian women living with HIV: a secondary analysis of a randomised controlled trial.BMJ Open已检查 1 张 PubMed Figure,均未识别为 KM 图:Figure 1:CONSORT/入组流程图。PMID 41120170PMC125425442025-Oct-200.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage).Br J DermatolPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40985295无 PMCID2025-Oct-170.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and Hypoglycemia Profile of Once-weekly Insulin Icodec vs Once-daily Comparators Across Demographic Subgroups.J Clin Endocrinol Metab已检查 2 张 PubMed Figure,均未识别为 KM 图:Figure 1:森林图/亚组分析图;Figure 2:森林图/亚组分析图。PMID 40102962PMC125274272025-Oct-160.98未发现恶性肿瘤人群证据。无 KM 图
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus.N Engl J MedPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 41092329无 PMCID2025-Oct-161.00The study is a randomized Phase 3 trial with a drug intervention and original results, but it is excluded because it is not an oncology trial and does not have a time-to-event primary or key secondary efficacy endpoint.无 KM 图
Mass Administration of Azithromycin to Infants in Mali to Reduce Mortality.N Engl J MedPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 41092331无 PMCID2025-Oct-160.98未发现恶性肿瘤人群证据。无 KM 图
Improved Iron Overload with Pegcetacoplan in Eculizumab-Experienced Patients with Paroxysmal Nocturnal Hemoglobinuria.Int J Mol Sci已检查 5 张 PubMed Figure,均未识别为 KM 图:Figure 1:AI 判定为 other;Figure 2:AI 判定为 other;Figure 3:AI 判定为 other;Figure 4:AI 判定为 other;Figure 5:研究设计图。PMID 41155315PMC125641552025-Oct-150.98未发现恶性肿瘤人群证据。无 KM 图
Improvements in health-related quality of life with esketamine nasal spray versus quetiapine extended release.Eur PsychiatryPMID 41084764PMC126461212025-Oct-140.98未发现恶性肿瘤人群证据。已完成
A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19.Nat Commun入排复审未纳入:未发现恶性肿瘤人群证据。PMID 41087376PMC125214072025-Oct-140.98未发现恶性肿瘤人群证据。无 KM 图
Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial.BMC Med已检查 1 张 PubMed Figure,均未识别为 KM 图:Fig. 1:AI 判定为 flow diagram。PMID 41088165PMC125225512025-Oct-140.98未发现恶性肿瘤人群证据。无 KM 图
[Efficacy and clinical remission in patients with severe asthma and blood eosinophil counts ≥150 cells/μl treated with benralizumab: a sub-analysis of the Phase 3 MIRACLE study].Zhonghua Jie He He Hu Xi Za ZhiPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 41073307无 PMCID2025-Oct-120.98未发现恶性肿瘤人群证据。无 KM 图
Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study.LancetPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 41016405无 PMCID2025-Oct-110.98未发现恶性肿瘤人群证据。无 KM 图
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.LancetPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 41045938无 PMCID2025-Oct-110.98未发现恶性肿瘤人群证据。无 KM 图
Self-administration of rozanolixizumab via manual push and infusion pump methods in patients with generalised myasthenia gravis: a randomised, phase 3, open-label, crossover study.J Neurol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 6 张 PMC Figure,均未识别为 KM 图:Fig. 1:研究设计图;Fig. 2:非 KM 图;Fig. 3:非 KM 图;Fig. 4:AI 判定为 other;Fig. 5:非 KM 图;另有 1 张未列出。PMID 41074934PMC125152072025-Oct-110.98未发现恶性肿瘤人群证据。无 KM 图
A phase 3, randomized trial to evaluate lot-to-lot consistency of V116, an adult-specific pneumococcal conjugate vaccine (STRIDE-4).MedPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40543503无 PMCID2025-Oct-100.98未发现恶性肿瘤人群证据。无 KM 图
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.J Clin Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 40825164无 PMCID2025-Oct-100.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study.J Clin Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 40829093无 PMCID2025-Oct-100.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study.J Clin OncolPMID 40902136PMC125094372025-Oct-100.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。已完成
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial.Blood疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 40499010无 PMCID2025-Oct-090.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma.Blood入排复审未纳入:The record is a preclinical study, not an original formal-result report of a human Phase III/IIIb or Phase II/III randomized trial. The abstract details only preclinical investigations in animal models and translational studies with patient-derived cells, without reporting the primary/key secondary time-to-event efficacy endpoint (e.g., OS, PFS) from a definitive human trial.PMID 40749164PMC128246902025-Oct-090.95The record is a preclinical study, not an original formal-result report of a human Phase III/IIIb or Phase II/III randomized trial. The abstract details only preclinical investigations in animal models and translational studies with patient-derived cells, without reporting the primary/key secondary time-to-event efficacy endpoint (e.g., OS, PFS) from a definitive human trial.无 KM 图
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.N Engl J Med已检查 2 张 PubMed Figure,均未识别为 KM 图:Figure 1:AI 判定为 other;Figure 2:森林图/亚组分析图。PMID 40888730PMC76180892025-Oct-090.98未发现恶性肿瘤人群证据。无 KM 图
Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial.Circulation疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 5 张 PMC Figure,均未识别为 KM 图:Figure 1.:非 KM 图;Figure 2.:非 KM 图;Figure 3.:非 KM 图;Figure 4.:非 KM 图;Figure 5.:非 KM 图。PMID 40910168PMC124930912025-Oct-070.98未发现恶性肿瘤人群证据。无 KM 图
Noninferiority Study of Purified Vero Rabies Vaccine-Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies Vaccines.Clin Infect Dis已检查 3 张 PubMed Figure,均未识别为 KM 图:Graphical Abstract:AI 判定为 other;Figure 1:AI 判定为 other;Figure 2:AI 判定为 other。PMID 39587931PMC124979472025-Oct-060.98未发现恶性肿瘤人群证据。无 KM 图
Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY).Clin Infect Dis已检查 5 张 PubMed Figure,均未识别为 KM 图:Graphical Abstract:AI 判定为 other;Figure 1:AI 判定为 multi panel km;Figure 2:AI 判定为 other;Figure 3:AI 判定为 other;Figure 4:AI 判定为 other。PMID 39656748PMC124979572025-Oct-060.98未发现恶性肿瘤人群证据。无 KM 图
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY).Clin Infect DisPMID 40410927PMC124979592025-Oct-060.98未发现恶性肿瘤人群证据。已完成
Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003).Blood Cancer JPMID 41052983PMC125012072025-Oct-060.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。已完成
Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses.Blood Cancer JPMID 41053004PMC125008552025-Oct-060.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。已完成
Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Antidepressant Tachyphylaxis: An Exploratory Post Hoc Analysis From a Phase 3 Randomized Controlled Trial.J Clin PsychiatryPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 41060071无 PMCID2025-Oct-060.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and safety of tegoprazan (LXI-15028) vs . esomeprazole in patients with erosive esophagitis: A multicenter, randomized, double-blind, non-inferiority phase Ⅲ trial.Chin Med J (Engl)已检查 2 张 PubMed Figure,均未识别为 KM 图:Figure 1:AI 判定为 flow diagram;Figure 2:生活质量量表图。PMID 39474720PMC124879122025-Oct-050.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamide.RMD Open已检查 2 张 PubMed Figure,均未识别为 KM 图:Figure 1:AI 判定为 other;Figure 2:AI 判定为 other。PMID 41052893PMC125064552025-Oct-050.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial.LancetPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40975112无 PMCID2025-Oct-040.98未发现恶性肿瘤人群证据。无 KM 图
Immunogenicity and safety of a meningococcal a conjugate vaccine administered with routine EPI vaccines in African infants and toddlers.VaccinePubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40966979无 PMCID2025-Oct-030.98未发现恶性肿瘤人群证据。无 KM 图
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia.N Engl J MedPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40888739无 PMCID2025-Oct-020.98未发现恶性肿瘤人群证据。无 KM 图
Clesrovimab for Prevention of RSV Disease in Healthy Infants.N Engl J MedPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40961446无 PMCID2025-Oct-020.98未发现恶性肿瘤人群证据。无 KM 图
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial.Am J Gastroenterol已检查 7 张 PubMed Figure,均未识别为 KM 图:captionless-figure:AI 判定为 other;Figure 1:AI 判定为 other;Figure 2:AI 判定为 other;Figure 3:AI 判定为 other;Figure 4:AI 判定为 other;另有 2 张未列出。PMID 39773524PMC124876592025-Oct-010.98未发现恶性肿瘤人群证据。无 KM 图
Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program.Inflamm Bowel Dis已检查 3 张 PubMed Figure,均未识别为 KM 图:Graphical Abstract:AI 判定为 other;Figure 1:森林图/亚组分析图;Figure 2:森林图/亚组分析图。PMID 40036804PMC125585782025-Oct-010.98未发现恶性肿瘤人群证据。无 KM 图
Long-term risk of major cardiac events in breast cancer patients treated with intensity-modulated and 3-dimensional conformal radiotherapy: Secondary analysis of a randomized clinical trial.Int J CancerPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40345828无 PMCID2025-Oct-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。无 KM 图
Acute and Late Radiation-Related Toxicity After Treatment of Locally Advanced Rectal Cancer With Intensity Modulated Radiation Therapy Compared With 3-Dimensional Conformal Radiation Therapy in the RAPIDO Trial.Int J Radiat Oncol Biol PhysPubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。PMID 40354950无 PMCID2025-Oct-010.95The study meets criteria for oncology, human, randomized, phase III, drug intervention, and original result. However, it is excluded because the primary endpoint is radiation-related toxicity (a safety endpoint), not a time-to-event efficacy endpoint such as OS, PFS, DFS, EFS, RFS, or TTP. The analysis uses logistic regression for binary outcomes, not survival analysis or hazard ratios.无 KM 图
Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group.Neuro Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 40485042PMC128335272025-Oct-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Automated detection of spinal bone marrow oedema in axial spondyloarthritis: training and validation using two large phase 3 trial datasets.Rheumatology (Oxford)入排复审未纳入:未发现恶性肿瘤人群证据。PMID 40489668PMC124941952025-Oct-010.98未发现恶性肿瘤人群证据。无 KM 图